ZMYM2 inhibits NANOG-mediated reprogramming. (2019)

First Author: Lawrence M
Attributed to:  Wellcome Trust MRC Cambridge Stem Cell Institute funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.12688/wellcomeopenres.15250.1

PubMed Identifier: 31363497

Publication URI: http://europepmc.org/abstract/MED/31363497

Type: Journal Article/Review

Volume: 4

Parent Publication: Wellcome open research

ISSN: 2398-502X